ERBB2 and cancer: Despite of the low PD-L1 expression on primary cancer cells, enhanced tumor killing and cytokine release were observed for HER2.28ζ/PD-L1.BB CAR-T cells as compared to HER2.28ζ CAR-T cells (Fig. 3j, k).